by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
MENLO PARK, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq:GERN) today provided updates on the clinical trials being conducted by Janssen Research & Development, LLC, of the telomerase inhibitor imetelstat. Planned internal reviews of...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
Rockville, MD, Sept. 12, 2016 (GLOBE NEWSWIRE) — and Osaka, Japan, Sept. 12, 2016 — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
CLEVELAND, Sept. 12, 2016 (GLOBE NEWSWIRE) — Athersys, Inc. (Nasdaq:ATHX) announced today the successful completion of Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review of the Clinical Trial Notification (CTN), allowing the commencement by HEALIOS...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced results from the Company’s Phase 1A study in healthy volunteers evaluating oral non-covalent BTK inhibitor SNS-062. The study demonstrated...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 12, 2016 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) announced that, as expected, the independent data monitoring committee (DMC) has completed its review of the first pre-specified interim efficacy...